(Q51055442)

27 March 2018

title

Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. (English)

1 reference

27 March 2018

ATP-binding cassette, sub-family D (ALD), member 1

main subject

1 reference

GOA release 2020-03-11

1 reference

1 reference

1 reference

3

1 reference

27 March 2018

Isabel Fabregat

5

1 reference

27 March 2018

Jordi Boada

7

1 reference

27 March 2018

Reinald Pamplona

10

1 reference

27 March 2018

Francesc Villarroya

11

1 reference

27 March 2018

Aurora Pujol

14

1 reference

27 March 2018

Stéphane Fourcade

object named as

S Fourcade

13

0 references

Manuel Portero-Otin

12

object named as

M Portero-Otín

1 reference

27 March 2018

author name string

J López-Erauskin

1

1 reference

27 March 2018

J Galino

2

1 reference

27 March 2018

J M Cuezva

4

1 reference

27 March 2018

D Cacabelos

6

1 reference

27 March 2018

J Martínez

8

1 reference

27 March 2018

I Ferrer

9

1 reference

27 March 2018

publication date

20 April 2013

1 reference

27 March 2018

published in

Human Molecular Genetics

1 reference

27 March 2018

volume

22

1 reference

27 March 2018

issue

16

1 reference

27 March 2018

page(s)

3296-3305

1 reference

27 March 2018

General aspects and neuropathology of X-linked adrenoleukodystrophy.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Adreno-leukodystrophy: oxidative stress of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mitochondrial bioenergetics and dynamics interplay in complex I-deficient fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Oxidative stress and altered mitochondrial function in neurodegenerative diseases: lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Simple quantitative detection of mitochondrial superoxide production in live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Highly resistant macromolecular components and low rate of generation of endogenous damage: two key traits of longevity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mitochondria: are they the seat of senescence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mitochondrial matters of the brain: the role in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mitochondrial functional alterations in relation to pathophysiology of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Mechanism of toxicity of the branched-chain fatty acid phytanic acid, a marker of Refsum disease, in astrocytes involves mitochondrial impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Rotenone-like action of the branched-chain phytanic acid induces oxidative stress in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

A mouse model for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

Method for in situ detection of the mitochondrial function in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDT186

21 January 2018

Identifiers

DOI

10.1093/HMG/DDT186

1 reference

27 March 2018

1 reference

27 March 2018